Lv4
548 积分 2025-06-12 加入
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
2个月前
已完结
Venetoclax combined with azacitidine in elderly acute myeloid leukemia: A retrospective comparison of 14-day vs 28-day dosing regimens
3个月前
已完结
[Real-World Study of 21-Day Venetoclax Plus Azacitidine Regimen in the Treatment of Newly Diagnosed Unfit-Acute Myeloid Leukemia]
3个月前
已关闭
Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
3个月前
已关闭
The approach of HMA plus VEN with or without BMT for all patients with AML
3个月前
已关闭
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML
3个月前
已关闭
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
3个月前
已完结
Are you ready for it? VEN-HMA for younger patients with AML
3个月前
已关闭
Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia
3个月前
已完结
皖公网安备34019202002308
